Medicare's New Trick: Benchmarking Drugs Against Global Prices
Published Date: 12/23/2025
Proposed Rule
Summary
The GLOBE Model is a new plan to help Medicare pay less for certain medicines by using a global price benchmark. This change affects Medicare patients and drug makers, aiming to save money while keeping care quality high. Comments on this plan are open until February 23, 2026, so everyone has a chance to weigh in before it moves forward.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 1 costs, 1 mixed.
Manufacturers must pay GLOBE rebates based on global prices
CMS proposes mandatory participation for all manufacturers of Part B rebatable drugs that are designated as GLOBE Model drugs; those manufacturers would pay GLOBE Model rebates into the Medicare Part B account when the specified amount exceeds a benchmark based on international drug pricing. CMS states the benchmark-based GLOBE Model rebate would not be less than any rebates owed under the existing Medicare Part B Drug Inflation Rebate Program, and manufacturers may submit a Suggestion of Error only for mathematical errors.
CMS estimates multi-billion dollar Medicare savings
CMS estimates the GLOBE Model would reduce overall Medicare Part B net spending by $11.9 billion over the 7-year model period, including about $8.4 billion in Medicare Part B FFS savings, $7.5 billion in Medicare Advantage savings, and about $4.0 billion in premium offset impacts; CMS also estimates about $1.0 billion in Medicaid savings (roughly $0.7 billion federal and $0.3 billion state). When annualized, CMS estimates approximately $2.3 billion in Medicare Part B FFS savings over the 7-year period.
Selected Medicare patients get lower coinsurance
About 25 percent of traditional Medicare Part B fee-for-service beneficiaries in selected geographic areas would be placed in the GLOBE Model cohort. When those beneficiaries receive an included GLOBE Model drug on an applicable date of service, their coinsurance would be reduced (for example, CMS gives an example where a $100 Medicare allowed amount with a reduced coinsurance of 10 percent results in $10 owed by the beneficiary and $90 paid by Medicare, instead of the usual $20/$80 split).
CMS selects cohort; beneficiaries cannot appeal selection
CMS would select which beneficiaries are in the GLOBE Model cohort (based on a beneficiary's address of record in selected geographic areas) and selection would not be subject to appeal; beneficiaries must have traditional Medicare Part B FFS as their primary payer and must not be enrolled in Medicare Advantage, a section 1876 cost plan, or certain prepayment plans to be eligible for cohort inclusion. Providers and suppliers would continue to buy and bill for GLOBE Model drugs as usual, but providers must reduce beneficiary coinsurance when the GLOBE Model reduced coinsurance applies.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12069 — Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
This new rule makes sure the groups that check Medicare providers play fair and follow clear rules to avoid conflicts of interest. It updates how psychiatric hospitals are reviewed and tightens rules for providers who lost their Medicare status but want back in. These changes affect Medicare providers and accrediting groups, start June 16, 2027, and aim to keep care safe and trustworthy.
2026-10890 — Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model
Starting July 1, 2026, Medicare is updating the Increasing Organ Transplant Access (IOTA) Model to help kidney transplant hospitals do even better at getting more people transplanted and improving care quality. These changes affect hospitals involved in kidney transplants and aim to make the process smoother and more effective, with new payment rules that reward success. This update is part of a 6-year plan running through 2031 to save more lives and boost patient experience.
2026-10292 — Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments
This proposed rule changes how states can pay Medicaid managed care plans and certain doctors to make sure payments are fair, efficient, and encourage enough providers to offer quality care. It affects states, Medicaid managed care organizations, and targeted Medicaid practitioners, aiming to keep payments balanced and services available. Comments on these changes are open until July 21, 2026, so stakeholders have time to weigh in before it’s finalized.
2026-10050 — Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program
Starting in 2027, health insurance plans on federal and state marketplaces will see new rules to make coverage fairer and easier to use. These changes affect insurance companies, agents, and people buying plans, including new fees, penalties, and better protections for those with hardships. Expect updates on plan quality, dental coverage limits, and longer-term catastrophic plans, all aiming to keep your health coverage solid and affordable.
2026-07205 — Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges
This new rule will help Medicare, Medicaid, CHIP, and health plan companies share patient info more easily and speed up drug approval requests. It affects Medicare Advantage, Medicaid, CHIP, and health plans on federal exchanges, aiming to make care smoother and faster. These changes will start soon and could save time and money by cutting red tape.
2026-04797 — Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction
This document fixes some typos and technical mistakes in the Medicare and Medicaid payment rules for 2026. It affects doctors, healthcare providers, and anyone using Medicare Part B by clarifying payment policies and program requirements starting January 1, 2026. These corrections help make sure payments and coverage rules are clear and accurate, so everyone gets paid right and on time.
Previous / Next Documents
Previous: 2025-23693 — Transparency in Coverage
Starting soon, health plans and insurers must share clearer, easier-to-understand price info for medical services. This means better details on what you’ll pay in-network and out-of-network, with more frequent updates and extra info like plan types and provider networks. These changes affect most group and individual health plans and aim to help you shop smarter and save money by December 2026.
Next: 2025-23704 — Debt Collection Authorities Under the Debt Collection Improvement Act of 1996
The Treasury is updating rules for the Treasury Offset Program, which helps collect government debts by taking money from payments owed to people who owe the government. These changes make the rules clearer, bring back some flexible options, and add new powers to improve debt collection. If you’re involved with government payments or debts, watch out—comments on these updates are open until February 23, 2026.